Institutional BioSafety Committee

The purpose of the Augusta University, Institutional Biosafety Committee (IBC) is to ensure institutional compliance with laws and regulations governing research with biohazardous materials to include pathogenic microorganisms, infectious materials, recombinant and synthetic nucleic acids (r/s NA), and select agents/toxins and to establish policies, procedures, and practices to ensure that research at Augusta University does not present unacceptable risks to the health or safety of faculty, staff, students, visitors, or the general public.

Charge: The IBC implements CDC guidelines published in Biosafety in Microbiological and Biomedical Laboratories, 5th ed, 2009; NIH guidelines published in NIH Guidelines for Research Involving Recombinant DNA, April 2016; and federal regulations governing CDC/USDA Select Agents published in DHHS 42 Code of Federal Regulations Part 73, Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review, Proposed Rule.

All research and instruction at Augusta University involving the following materials below, requires registration with the Biological Safety Office and approval from the IBC. The IBC reviews Biosafety Protocol (BSP) applications once per month. BSPs involving r/s NA must be submitted to biosafety@augusta.edu by the 1stof the month, to be considered for IBC review during that month's meeting.